LOGIN  |  REGISTER
Chimerix

CareCloud to Highlight Chronic Care Management and Remote Patient Monitoring Solutions at AMGA Annual Conference

March 21, 2023 | Last Trade: US$1.11 0.03 -2.63

SOMERSET, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced it will showcase its innovative suite of digital health solutions in booth 537 at the American Medical Group Association (AMGA) Annual Conference from March 28-31 in Chicago.

CareCloud Wellness, launched in early 2022, is a digital health platform offering chronic care management and remote patient monitoring to reduce the burden of in-person visits on physicians, while empowering patients to manage their health proactively. It also enables providers to participate in the government's chronic care management incentive program, allowing them to increase revenue streams and grow their practices. CareCloud Wellness leverages the latest technologies to remotely monitor patients' health status, track medication adherence, and manage care plans in real-time, allowing providers to detect potential issues before they escalate. Overall, the platform represents a major step forward in healthcare innovation, enabling providers to deliver more effective care, while empowering patients to take control of their health and well-being.

CareCloud’s Karl Johnson, who will be in CareCloud’s booth at the conference, highlighted the potential benefits of offering chronic care management and remote patient monitoring services. “These powerful digital health services are often covered by Medicare and some private insurers, which can provide a new revenue stream for medical practices. Additionally, they can improve the quality of care and patient outcomes, leading to increased patient satisfaction and referrals. By reducing the need for in-person visits and associated costs, medical practices can attract more patients and improve their financial performance and reputation.”

AMGA is a highly respected organization representing a significant part of the U.S. population, with a membership of 400 medical groups and health systems, including 177,000 physicians and 142 million patients. The Annual Conference is a major event for medical group and health system executives to share their experiences and learn about the most effective healthcare management and delivery practices.

For more information about CareCloud's comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

SOURCE CareCloud

Company Contact:
Bill Korn
Chief Financial Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB